FDA approval Azithromycin - Zithromax clinical trails
Home       Treatment        Side Effects       Pfizer       FDA Aproval       HIV AIDS

 

FDA approval for Azithromycin -  Zithromax

In the US, Azithromycin was approved by the FDA on the 14th of June, 1996. The manufacturer of the pill strictly advises that the capsules ought to be kept at less than 30°C (86°F) and suspension must be kept between 5° and 30°C (41° and 86°F). Azithromycin treatment is successful against vulnerable bacteria causing infections of the middle ear, laryngitis, tonsillitis, bronchitis, pneumonia, throat infections and sinuses. The drug is also effective fighting against some sexually transmitted infectious diseases, for example non-gonococcal urethritis and cervicitis.

Clinical trials have shown that Azithromycin ought to be taken at least one hour pending to or two hours following meals. This is so because it might attach to food and will not be absorbed from the lining of the intestine. In case of the majority of infections, Zithromax is prescribed once daily for a fairly small course of treatment (generally five days), where the first dose is frequently a double dose, two times as much as the regular of doses given. In case of heightened bacterial sinusitis, Zithromax may be given once daily for at least three days. Zithromax more often than not is given as a solitary 2 gm dose.

Future sale of this drug does not appear to be at risk for despite its side effects it does have an over all positive effect. In the negative case Azithromycin or Zithromax is able to decrease the liver's metabolism of the non sedating anti-histamines, terfenadine and astemizole. Amplified levels of these antihistamines within the body will most likely result in potentially fatal heart rhythm irregularities.
 

Home       Treatment        Side Effects       Pfizer       FDA Aproval       HIV AIDS